Building a Healthier WorldBuilding a Healthier World

CNX Therapeutics is a European pharmaceutical company dedicated to improving the lives of patients through the supply of essential medicines.

We commercialise and distribute a portfolio of speciality brands and hospital products in Europe, and through partners, in over 35 countries worldwide.

Our vision is to become a recognised partner of choice through our commercial excellence, patient focus and presence across Europe.

We aim to have a positive impact on society through our pioneering focus on our Environment, Social and Governance (ESG) goals.

Latest News

CNX Therapeutics appoints Ben Moore as Vice President, Corporate Development

CNX Therapeutics is proud to announce that Ben Moore has joined CNX Therapeutics as our Vice President, Corporate Development.

Ben has worked in the pharmaceutical industry for over 15 years and joins from Mundipharma International where he was Senior Director, Corporate and Business Development.